nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—kidney cancer	0.243	1	CbGaD
Fexofenadine—SLCO2B1—Erlotinib—kidney cancer	0.116	0.189	CbGbCtD
Fexofenadine—SLCO1B3—Paclitaxel—kidney cancer	0.0942	0.154	CbGbCtD
Fexofenadine—SLCO1B1—Pazopanib—kidney cancer	0.084	0.137	CbGbCtD
Fexofenadine—ABCB1—Temsirolimus—kidney cancer	0.0458	0.0747	CbGbCtD
Fexofenadine—CYP2D6—Temsirolimus—kidney cancer	0.0431	0.0704	CbGbCtD
Fexofenadine—ABCB1—Pazopanib—kidney cancer	0.0241	0.0392	CbGbCtD
Fexofenadine—CYP2D6—Pazopanib—kidney cancer	0.0227	0.037	CbGbCtD
Fexofenadine—ABCB1—Dactinomycin—kidney cancer	0.022	0.0359	CbGbCtD
Fexofenadine—ABCB1—Gemcitabine—kidney cancer	0.0174	0.0284	CbGbCtD
Fexofenadine—ABCB1—Erlotinib—kidney cancer	0.0172	0.028	CbGbCtD
Fexofenadine—CYP2D6—Erlotinib—kidney cancer	0.0162	0.0264	CbGbCtD
Fexofenadine—ABCB1—Paclitaxel—kidney cancer	0.0157	0.0256	CbGbCtD
Fexofenadine—ABCB1—Sorafenib—kidney cancer	0.014	0.0228	CbGbCtD
Fexofenadine—ABCB1—Vinblastine—kidney cancer	0.0138	0.0225	CbGbCtD
Fexofenadine—ABCB1—Vincristine—kidney cancer	0.0135	0.0221	CbGbCtD
Fexofenadine—CYP2D6—Sorafenib—kidney cancer	0.0132	0.0214	CbGbCtD
Fexofenadine—CYP2D6—Vinblastine—kidney cancer	0.013	0.0212	CbGbCtD
Fexofenadine—ABCB1—Sunitinib—kidney cancer	0.0113	0.0184	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—kidney cancer	0.00847	0.0138	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—kidney cancer	0.00798	0.013	CbGbCtD
Fexofenadine—Loperamide—POMC—kidney cancer	0.00108	0.507	CrCbGaD
Fexofenadine—Lomitapide—ABCB1—kidney cancer	0.000542	0.254	CrCbGaD
Fexofenadine—Epistaxis—Paclitaxel—kidney cancer	0.000336	0.00237	CcSEcCtD
Fexofenadine—Infection—Sunitinib—kidney cancer	0.000336	0.00237	CcSEcCtD
Fexofenadine—Sinusitis—Paclitaxel—kidney cancer	0.000334	0.00236	CcSEcCtD
Fexofenadine—Pain—Erlotinib—kidney cancer	0.000334	0.00236	CcSEcCtD
Fexofenadine—Myalgia—Dactinomycin—kidney cancer	0.000334	0.00236	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vinblastine—kidney cancer	0.000332	0.00235	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Everolimus—kidney cancer	0.000331	0.00234	CcSEcCtD
Fexofenadine—Vomiting—Pazopanib—kidney cancer	0.000326	0.0023	CcSEcCtD
Fexofenadine—Rash—Pazopanib—kidney cancer	0.000323	0.00229	CcSEcCtD
Fexofenadine—Nausea—Temsirolimus—kidney cancer	0.000323	0.00229	CcSEcCtD
Fexofenadine—Dermatitis—Pazopanib—kidney cancer	0.000323	0.00228	CcSEcCtD
Fexofenadine—Agitation—Vincristine—kidney cancer	0.000322	0.00228	CcSEcCtD
Fexofenadine—Back pain—Gemcitabine—kidney cancer	0.000321	0.00227	CcSEcCtD
Fexofenadine—Abdominal pain—Vinblastine—kidney cancer	0.000321	0.00227	CcSEcCtD
Fexofenadine—Headache—Pazopanib—kidney cancer	0.000321	0.00227	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00032	0.00226	CcSEcCtD
Fexofenadine—Abdominal pain—Everolimus—kidney cancer	0.00032	0.00226	CcSEcCtD
Fexofenadine—Body temperature increased—Everolimus—kidney cancer	0.00032	0.00226	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000319	0.00226	CcSEcCtD
Fexofenadine—Infection—Dactinomycin—kidney cancer	0.000318	0.00225	CcSEcCtD
Fexofenadine—Abdominal discomfort—Capecitabine—kidney cancer	0.000314	0.00222	CcSEcCtD
Fexofenadine—Dyspnoea—Sorafenib—kidney cancer	0.000313	0.00221	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—kidney cancer	0.000311	0.0022	CcSEcCtD
Fexofenadine—Dyspepsia—Sorafenib—kidney cancer	0.000309	0.00219	CcSEcCtD
Fexofenadine—Abdominal pain—Erlotinib—kidney cancer	0.000308	0.00218	CcSEcCtD
Fexofenadine—Body temperature increased—Erlotinib—kidney cancer	0.000308	0.00218	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000308	0.00218	CcSEcCtD
Fexofenadine—Insomnia—Sunitinib—kidney cancer	0.000305	0.00216	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000304	0.00215	CcSEcCtD
Fexofenadine—Nausea—Pazopanib—kidney cancer	0.000304	0.00215	CcSEcCtD
Fexofenadine—Fatigue—Sorafenib—kidney cancer	0.000303	0.00214	CcSEcCtD
Fexofenadine—Dyspnoea—Sunitinib—kidney cancer	0.000301	0.00213	CcSEcCtD
Fexofenadine—Pain—Sorafenib—kidney cancer	0.0003	0.00212	CcSEcCtD
Fexofenadine—Hypersensitivity—Vinblastine—kidney cancer	0.000299	0.00212	CcSEcCtD
Fexofenadine—Myalgia—Vincristine—kidney cancer	0.000298	0.00211	CcSEcCtD
Fexofenadine—Hypersensitivity—Everolimus—kidney cancer	0.000298	0.00211	CcSEcCtD
Fexofenadine—Dyspepsia—Sunitinib—kidney cancer	0.000297	0.0021	CcSEcCtD
Fexofenadine—Flushing—Paclitaxel—kidney cancer	0.000296	0.0021	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000291	0.00206	CcSEcCtD
Fexofenadine—Asthenia—Vinblastine—kidney cancer	0.000291	0.00206	CcSEcCtD
Fexofenadine—Fatigue—Sunitinib—kidney cancer	0.000291	0.00206	CcSEcCtD
Fexofenadine—Asthenia—Everolimus—kidney cancer	0.00029	0.00205	CcSEcCtD
Fexofenadine—Cough—Gemcitabine—kidney cancer	0.00029	0.00205	CcSEcCtD
Fexofenadine—Pain—Sunitinib—kidney cancer	0.000289	0.00204	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000287	0.00203	CcSEcCtD
Fexofenadine—Pruritus—Everolimus—kidney cancer	0.000286	0.00202	CcSEcCtD
Fexofenadine—Anaphylactic shock—Vincristine—kidney cancer	0.000286	0.00202	CcSEcCtD
Fexofenadine—Infection—Vincristine—kidney cancer	0.000284	0.00201	CcSEcCtD
Fexofenadine—Myalgia—Gemcitabine—kidney cancer	0.000283	0.002	CcSEcCtD
Fexofenadine—Asthenia—Erlotinib—kidney cancer	0.00028	0.00198	CcSEcCtD
Fexofenadine—Urticaria—Sorafenib—kidney cancer	0.000279	0.00197	CcSEcCtD
Fexofenadine—Diarrhoea—Vinblastine—kidney cancer	0.000278	0.00197	CcSEcCtD
Fexofenadine—Body temperature increased—Sorafenib—kidney cancer	0.000277	0.00196	CcSEcCtD
Fexofenadine—Abdominal pain—Sorafenib—kidney cancer	0.000277	0.00196	CcSEcCtD
Fexofenadine—Diarrhoea—Everolimus—kidney cancer	0.000277	0.00196	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000276	0.00195	CcSEcCtD
Fexofenadine—Pruritus—Erlotinib—kidney cancer	0.000276	0.00195	CcSEcCtD
Fexofenadine—Fatigue—Dactinomycin—kidney cancer	0.000276	0.00195	CcSEcCtD
Fexofenadine—Epistaxis—Capecitabine—kidney cancer	0.000275	0.00195	CcSEcCtD
Fexofenadine—Flatulence—Paclitaxel—kidney cancer	0.000274	0.00194	CcSEcCtD
Fexofenadine—Pain—Dactinomycin—kidney cancer	0.000273	0.00194	CcSEcCtD
Fexofenadine—Tension—Paclitaxel—kidney cancer	0.000273	0.00193	CcSEcCtD
Fexofenadine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000271	0.00192	CcSEcCtD
Fexofenadine—Nervousness—Paclitaxel—kidney cancer	0.00027	0.00191	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000269	0.00191	CcSEcCtD
Fexofenadine—Infection—Gemcitabine—kidney cancer	0.000269	0.00191	CcSEcCtD
Fexofenadine—Back pain—Paclitaxel—kidney cancer	0.000269	0.0019	CcSEcCtD
Fexofenadine—Dizziness—Vinblastine—kidney cancer	0.000268	0.0019	CcSEcCtD
Fexofenadine—Dizziness—Everolimus—kidney cancer	0.000267	0.00189	CcSEcCtD
Fexofenadine—Body temperature increased—Sunitinib—kidney cancer	0.000267	0.00189	CcSEcCtD
Fexofenadine—Abdominal pain—Sunitinib—kidney cancer	0.000267	0.00189	CcSEcCtD
Fexofenadine—Diarrhoea—Erlotinib—kidney cancer	0.000267	0.00189	CcSEcCtD
Fexofenadine—Vision blurred—Paclitaxel—kidney cancer	0.000262	0.00185	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000261	0.00185	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00026	0.00184	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—kidney cancer	0.00026	0.00184	CcSEcCtD
Fexofenadine—Hypersensitivity—Sorafenib—kidney cancer	0.000259	0.00183	CcSEcCtD
Fexofenadine—Insomnia—Vincristine—kidney cancer	0.000258	0.00183	CcSEcCtD
Fexofenadine—Vomiting—Vinblastine—kidney cancer	0.000258	0.00183	CcSEcCtD
Fexofenadine—Dizziness—Erlotinib—kidney cancer	0.000258	0.00183	CcSEcCtD
Fexofenadine—Vomiting—Everolimus—kidney cancer	0.000257	0.00182	CcSEcCtD
Fexofenadine—Agitation—Paclitaxel—kidney cancer	0.000255	0.00181	CcSEcCtD
Fexofenadine—Rash—Everolimus—kidney cancer	0.000255	0.0018	CcSEcCtD
Fexofenadine—Dermatitis—Everolimus—kidney cancer	0.000255	0.0018	CcSEcCtD
Fexofenadine—Headache—Vinblastine—kidney cancer	0.000254	0.0018	CcSEcCtD
Fexofenadine—Angioedema—Paclitaxel—kidney cancer	0.000254	0.0018	CcSEcCtD
Fexofenadine—Headache—Everolimus—kidney cancer	0.000253	0.00179	CcSEcCtD
Fexofenadine—Abdominal pain—Dactinomycin—kidney cancer	0.000253	0.00179	CcSEcCtD
Fexofenadine—Body temperature increased—Dactinomycin—kidney cancer	0.000253	0.00179	CcSEcCtD
Fexofenadine—Asthenia—Sorafenib—kidney cancer	0.000252	0.00178	CcSEcCtD
Fexofenadine—Hypersensitivity—Sunitinib—kidney cancer	0.000249	0.00176	CcSEcCtD
Fexofenadine—Pruritus—Sorafenib—kidney cancer	0.000248	0.00176	CcSEcCtD
Fexofenadine—Vomiting—Erlotinib—kidney cancer	0.000248	0.00176	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000247	0.00175	CcSEcCtD
Fexofenadine—Fatigue—Vincristine—kidney cancer	0.000246	0.00174	CcSEcCtD
Fexofenadine—Rash—Erlotinib—kidney cancer	0.000246	0.00174	CcSEcCtD
Fexofenadine—Dermatitis—Erlotinib—kidney cancer	0.000246	0.00174	CcSEcCtD
Fexofenadine—Palpitations—Paclitaxel—kidney cancer	0.000246	0.00174	CcSEcCtD
Fexofenadine—Insomnia—Gemcitabine—kidney cancer	0.000245	0.00173	CcSEcCtD
Fexofenadine—Headache—Erlotinib—kidney cancer	0.000244	0.00173	CcSEcCtD
Fexofenadine—Pain—Vincristine—kidney cancer	0.000244	0.00173	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—kidney cancer	0.000244	0.00173	CcSEcCtD
Fexofenadine—Flushing—Capecitabine—kidney cancer	0.000243	0.00172	CcSEcCtD
Fexofenadine—Cough—Paclitaxel—kidney cancer	0.000243	0.00172	CcSEcCtD
Fexofenadine—Asthenia—Sunitinib—kidney cancer	0.000242	0.00172	CcSEcCtD
Fexofenadine—Dyspnoea—Gemcitabine—kidney cancer	0.000242	0.00171	CcSEcCtD
Fexofenadine—Nausea—Vinblastine—kidney cancer	0.000241	0.00171	CcSEcCtD
Fexofenadine—Somnolence—Gemcitabine—kidney cancer	0.000241	0.00171	CcSEcCtD
Fexofenadine—Nausea—Everolimus—kidney cancer	0.00024	0.0017	CcSEcCtD
Fexofenadine—Diarrhoea—Sorafenib—kidney cancer	0.00024	0.0017	CcSEcCtD
Fexofenadine—Pruritus—Sunitinib—kidney cancer	0.000239	0.00169	CcSEcCtD
Fexofenadine—Myalgia—Paclitaxel—kidney cancer	0.000237	0.00168	CcSEcCtD
Fexofenadine—Hypersensitivity—Dactinomycin—kidney cancer	0.000236	0.00167	CcSEcCtD
Fexofenadine—Fatigue—Gemcitabine—kidney cancer	0.000234	0.00165	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vincristine—kidney cancer	0.000234	0.00165	CcSEcCtD
Fexofenadine—Dizziness—Sorafenib—kidney cancer	0.000232	0.00164	CcSEcCtD
Fexofenadine—Pain—Gemcitabine—kidney cancer	0.000232	0.00164	CcSEcCtD
Fexofenadine—Nausea—Erlotinib—kidney cancer	0.000232	0.00164	CcSEcCtD
Fexofenadine—Dry mouth—Paclitaxel—kidney cancer	0.000231	0.00164	CcSEcCtD
Fexofenadine—Diarrhoea—Sunitinib—kidney cancer	0.000231	0.00164	CcSEcCtD
Fexofenadine—Asthenia—Dactinomycin—kidney cancer	0.000229	0.00162	CcSEcCtD
Fexofenadine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000227	0.00161	CcSEcCtD
Fexofenadine—Abdominal pain—Vincristine—kidney cancer	0.000226	0.0016	CcSEcCtD
Fexofenadine—Body temperature increased—Vincristine—kidney cancer	0.000226	0.0016	CcSEcCtD
Fexofenadine—Infection—Paclitaxel—kidney cancer	0.000225	0.0016	CcSEcCtD
Fexofenadine—Flatulence—Capecitabine—kidney cancer	0.000225	0.00159	CcSEcCtD
Fexofenadine—Dizziness—Sunitinib—kidney cancer	0.000223	0.00158	CcSEcCtD
Fexofenadine—Vomiting—Sorafenib—kidney cancer	0.000223	0.00158	CcSEcCtD
Fexofenadine—Tachycardia—Paclitaxel—kidney cancer	0.000221	0.00157	CcSEcCtD
Fexofenadine—Rash—Sorafenib—kidney cancer	0.000221	0.00157	CcSEcCtD
Fexofenadine—Dermatitis—Sorafenib—kidney cancer	0.000221	0.00156	CcSEcCtD
Fexofenadine—Back pain—Capecitabine—kidney cancer	0.000221	0.00156	CcSEcCtD
Fexofenadine—Headache—Sorafenib—kidney cancer	0.00022	0.00156	CcSEcCtD
Fexofenadine—Diarrhoea—Dactinomycin—kidney cancer	0.000219	0.00155	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000218	0.00155	CcSEcCtD
Fexofenadine—Vision blurred—Capecitabine—kidney cancer	0.000215	0.00152	CcSEcCtD
Fexofenadine—Vomiting—Sunitinib—kidney cancer	0.000215	0.00152	CcSEcCtD
Fexofenadine—Body temperature increased—Gemcitabine—kidney cancer	0.000214	0.00152	CcSEcCtD
Fexofenadine—Rash—Sunitinib—kidney cancer	0.000213	0.00151	CcSEcCtD
Fexofenadine—Dermatitis—Sunitinib—kidney cancer	0.000213	0.00151	CcSEcCtD
Fexofenadine—Headache—Sunitinib—kidney cancer	0.000212	0.0015	CcSEcCtD
Fexofenadine—Hypersensitivity—Vincristine—kidney cancer	0.00021	0.00149	CcSEcCtD
Fexofenadine—Nausea—Sorafenib—kidney cancer	0.000208	0.00148	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000207	0.00146	CcSEcCtD
Fexofenadine—Insomnia—Paclitaxel—kidney cancer	0.000205	0.00145	CcSEcCtD
Fexofenadine—Asthenia—Vincristine—kidney cancer	0.000205	0.00145	CcSEcCtD
Fexofenadine—Vomiting—Dactinomycin—kidney cancer	0.000203	0.00144	CcSEcCtD
Fexofenadine—Dyspnoea—Paclitaxel—kidney cancer	0.000202	0.00143	CcSEcCtD
Fexofenadine—Somnolence—Paclitaxel—kidney cancer	0.000202	0.00143	CcSEcCtD
Fexofenadine—Palpitations—Capecitabine—kidney cancer	0.000202	0.00143	CcSEcCtD
Fexofenadine—Rash—Dactinomycin—kidney cancer	0.000202	0.00143	CcSEcCtD
Fexofenadine—Nausea—Sunitinib—kidney cancer	0.000201	0.00142	CcSEcCtD
Fexofenadine—Dyspepsia—Paclitaxel—kidney cancer	0.0002	0.00141	CcSEcCtD
Fexofenadine—Cough—Capecitabine—kidney cancer	0.000199	0.00141	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000196	0.00139	CcSEcCtD
Fexofenadine—Fatigue—Paclitaxel—kidney cancer	0.000196	0.00138	CcSEcCtD
Fexofenadine—Diarrhoea—Vincristine—kidney cancer	0.000195	0.00138	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—kidney cancer	0.000195	0.00138	CcSEcCtD
Fexofenadine—Asthenia—Gemcitabine—kidney cancer	0.000194	0.00138	CcSEcCtD
Fexofenadine—Myalgia—Capecitabine—kidney cancer	0.000194	0.00137	CcSEcCtD
Fexofenadine—Pain—Paclitaxel—kidney cancer	0.000194	0.00137	CcSEcCtD
Fexofenadine—Pruritus—Gemcitabine—kidney cancer	0.000192	0.00136	CcSEcCtD
Fexofenadine—Dry mouth—Capecitabine—kidney cancer	0.00019	0.00134	CcSEcCtD
Fexofenadine—Nausea—Dactinomycin—kidney cancer	0.00019	0.00134	CcSEcCtD
Fexofenadine—Dizziness—Vincristine—kidney cancer	0.000189	0.00134	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—kidney cancer	0.000188	0.00133	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000186	0.00131	CcSEcCtD
Fexofenadine—Diarrhoea—Gemcitabine—kidney cancer	0.000185	0.00131	CcSEcCtD
Fexofenadine—Infection—Capecitabine—kidney cancer	0.000185	0.00131	CcSEcCtD
Fexofenadine—Tachycardia—Capecitabine—kidney cancer	0.000182	0.00129	CcSEcCtD
Fexofenadine—Vomiting—Vincristine—kidney cancer	0.000182	0.00129	CcSEcCtD
Fexofenadine—Urticaria—Paclitaxel—kidney cancer	0.00018	0.00128	CcSEcCtD
Fexofenadine—Rash—Vincristine—kidney cancer	0.00018	0.00127	CcSEcCtD
Fexofenadine—Dermatitis—Vincristine—kidney cancer	0.00018	0.00127	CcSEcCtD
Fexofenadine—Body temperature increased—Paclitaxel—kidney cancer	0.000179	0.00127	CcSEcCtD
Fexofenadine—Abdominal pain—Paclitaxel—kidney cancer	0.000179	0.00127	CcSEcCtD
Fexofenadine—Headache—Vincristine—kidney cancer	0.000179	0.00127	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—kidney cancer	0.000177	0.00126	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—kidney cancer	0.000177	0.00125	CcSEcCtD
Fexofenadine—Vomiting—Gemcitabine—kidney cancer	0.000172	0.00122	CcSEcCtD
Fexofenadine—Rash—Gemcitabine—kidney cancer	0.000171	0.00121	CcSEcCtD
Fexofenadine—Dermatitis—Gemcitabine—kidney cancer	0.000171	0.00121	CcSEcCtD
Fexofenadine—Headache—Gemcitabine—kidney cancer	0.00017	0.0012	CcSEcCtD
Fexofenadine—Nausea—Vincristine—kidney cancer	0.00017	0.0012	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00017	0.0012	CcSEcCtD
Fexofenadine—Insomnia—Capecitabine—kidney cancer	0.000168	0.00119	CcSEcCtD
Fexofenadine—Hypersensitivity—Paclitaxel—kidney cancer	0.000167	0.00118	CcSEcCtD
Fexofenadine—Dyspnoea—Capecitabine—kidney cancer	0.000166	0.00117	CcSEcCtD
Fexofenadine—Dyspepsia—Capecitabine—kidney cancer	0.000164	0.00116	CcSEcCtD
Fexofenadine—Asthenia—Paclitaxel—kidney cancer	0.000163	0.00115	CcSEcCtD
Fexofenadine—Nausea—Gemcitabine—kidney cancer	0.000161	0.00114	CcSEcCtD
Fexofenadine—Fatigue—Capecitabine—kidney cancer	0.000161	0.00114	CcSEcCtD
Fexofenadine—Pruritus—Paclitaxel—kidney cancer	0.000161	0.00114	CcSEcCtD
Fexofenadine—Pain—Capecitabine—kidney cancer	0.000159	0.00113	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—kidney cancer	0.000157	0.00111	CcSEcCtD
Fexofenadine—Diarrhoea—Paclitaxel—kidney cancer	0.000155	0.0011	CcSEcCtD
Fexofenadine—Pimozide—ABCB1—kidney cancer	0.000155	0.0724	CrCbGaD
Fexofenadine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000152	0.00108	CcSEcCtD
Fexofenadine—Dizziness—Paclitaxel—kidney cancer	0.00015	0.00106	CcSEcCtD
Fexofenadine—Urticaria—Capecitabine—kidney cancer	0.000148	0.00105	CcSEcCtD
Fexofenadine—Abdominal pain—Capecitabine—kidney cancer	0.000147	0.00104	CcSEcCtD
Fexofenadine—Body temperature increased—Capecitabine—kidney cancer	0.000147	0.00104	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—kidney cancer	0.000145	0.00103	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—kidney cancer	0.000144	0.00102	CcSEcCtD
Fexofenadine—Vomiting—Paclitaxel—kidney cancer	0.000144	0.00102	CcSEcCtD
Fexofenadine—Rash—Paclitaxel—kidney cancer	0.000143	0.00101	CcSEcCtD
Fexofenadine—Dermatitis—Paclitaxel—kidney cancer	0.000143	0.00101	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—kidney cancer	0.000143	0.00101	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—kidney cancer	0.000142	0.00101	CcSEcCtD
Fexofenadine—Headache—Paclitaxel—kidney cancer	0.000142	0.00101	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—kidney cancer	0.000139	0.000981	CcSEcCtD
Fexofenadine—Hypersensitivity—Capecitabine—kidney cancer	0.000137	0.000971	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—kidney cancer	0.000135	0.000956	CcSEcCtD
Fexofenadine—Nausea—Paclitaxel—kidney cancer	0.000135	0.000954	CcSEcCtD
Fexofenadine—Fentanyl—ABCB1—kidney cancer	0.000134	0.0628	CrCbGaD
Fexofenadine—Asthenia—Capecitabine—kidney cancer	0.000134	0.000945	CcSEcCtD
Fexofenadine—Pruritus—Capecitabine—kidney cancer	0.000132	0.000932	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—kidney cancer	0.00013	0.00092	CcSEcCtD
Fexofenadine—Loperamide—ABCB1—kidney cancer	0.000129	0.0605	CrCbGaD
Fexofenadine—Cough—Doxorubicin—kidney cancer	0.000128	0.000908	CcSEcCtD
Fexofenadine—Diarrhoea—Capecitabine—kidney cancer	0.000127	0.000902	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—kidney cancer	0.000125	0.000886	CcSEcCtD
Fexofenadine—Dizziness—Capecitabine—kidney cancer	0.000123	0.000871	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—kidney cancer	0.000122	0.000867	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—kidney cancer	0.00012	0.000849	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—kidney cancer	0.000119	0.000844	CcSEcCtD
Fexofenadine—Vomiting—Capecitabine—kidney cancer	0.000118	0.000838	CcSEcCtD
Fexofenadine—Rash—Capecitabine—kidney cancer	0.000117	0.000831	CcSEcCtD
Fexofenadine—Dermatitis—Capecitabine—kidney cancer	0.000117	0.00083	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—kidney cancer	0.000117	0.000829	CcSEcCtD
Fexofenadine—Headache—Capecitabine—kidney cancer	0.000117	0.000826	CcSEcCtD
Fexofenadine—Nausea—Capecitabine—kidney cancer	0.000111	0.000783	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000109	0.000774	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—kidney cancer	0.000109	0.000768	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—kidney cancer	0.000107	0.000757	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—kidney cancer	0.000107	0.000755	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—kidney cancer	0.000106	0.000748	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—kidney cancer	0.000103	0.000732	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—kidney cancer	0.000103	0.000726	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—kidney cancer	9.81e-05	0.000695	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—kidney cancer	9.53e-05	0.000675	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—kidney cancer	9.49e-05	0.000672	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—kidney cancer	9.49e-05	0.000672	CcSEcCtD
Fexofenadine—Methadone—ABCB1—kidney cancer	9.19e-05	0.043	CrCbGaD
Fexofenadine—Hypersensitivity—Doxorubicin—kidney cancer	8.84e-05	0.000626	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—kidney cancer	8.61e-05	0.000609	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—kidney cancer	8.49e-05	0.000601	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—kidney cancer	8.21e-05	0.000581	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—kidney cancer	7.94e-05	0.000562	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—kidney cancer	7.63e-05	0.00054	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—kidney cancer	7.57e-05	0.000536	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—kidney cancer	7.56e-05	0.000535	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—kidney cancer	7.52e-05	0.000532	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—kidney cancer	7.13e-05	0.000505	CcSEcCtD
